Belbuca Revenue 'Immaterial,' Says JMP On Rx's Return To BioDelivery From Endo International

By: via Benzinga
JMP Securities reiterated its Market Outperform rating and $34 price target on Endo International plc - Ordinary Shares (NASDAQ: ENDP), ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.